Skip to main content
. 2022 Apr 12;12(4):970. doi: 10.3390/diagnostics12040970

Table 4.

Histopathological findings of 1162 cases.

Group Case Number Percentage (%)
Proliferative phase endometrium 205 17.64
Secretory phase endometrium 124 10.67
Menstrual phase endometrium 17 1.46
Exogenous hormones 72 6.20
Menopausal endometrium 53 4.56
Inadequate for analysis 188 16.18
Endometrial polyp 157 13.51
Endometrial hyperplasia 279 24.01
Malignant tumors 47 4.04
Endometritis 20 1.72
Total 1162 100